Home / Health / Breakthrough: Age Enzyme Injection Regenerates Knee Cartilage
Breakthrough: Age Enzyme Injection Regenerates Knee Cartilage
21 Jun
Summary
- Enzyme inhibitor injection shows promise in regenerating damaged cartilage.
- Study in mice indicates potential for reversing osteoarthritis effects.
- This new approach could offer an alternative to joint replacement surgery.
New research from Stanford Medicine presents a potential breakthrough in treating osteoarthritis, a debilitating condition impacting approximately 60 million U.S. adults. Current treatment options for worn-down knees are limited to pain management and eventual joint replacement, as cartilage is notoriously difficult to regenerate.
A study published in Science detailed how a single injection targeting the enzyme 15-PGDH, which increases with age and impedes cartilage repair, successfully rebuilt damaged cartilage in older mice. This innovative approach also prevented arthritis in about half of the test subjects.
Researchers observed that existing cartilage cells, known as chondrocytes, appeared to reset and mimic younger cells, suggesting a regenerative mechanism independent of stem cells. This finding, if applicable to humans, could fundamentally alter how joint damage is treated.
While this discovery is not yet available for patients, the 15-PGDH inhibitor is undergoing Phase 1 testing for age-related muscle weakness and has shown early signs of safety and efficacy. Stanford Medicine aims to launch further studies to assess its safety and effectiveness in regenerating cartilage in people with joint damage.
